JP2022517730A5 - - Google Patents
Info
- Publication number
- JP2022517730A5 JP2022517730A5 JP2021536757A JP2021536757A JP2022517730A5 JP 2022517730 A5 JP2022517730 A5 JP 2022517730A5 JP 2021536757 A JP2021536757 A JP 2021536757A JP 2021536757 A JP2021536757 A JP 2021536757A JP 2022517730 A5 JP2022517730 A5 JP 2022517730A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023005014A JP2023052437A (ja) | 2018-12-27 | 2023-01-17 | がんの処置のためのｔｇｆ－ベータｒ１（ａｌｋ５）阻害剤としての（ピリジン－２－イル）アミン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785616P | 2018-12-27 | 2018-12-27 | |
| US62/785,616 | 2018-12-27 | ||
| PCT/US2019/066993 WO2020139636A1 (en) | 2018-12-27 | 2019-12-17 | (pyridin-2-yl)amine derivatives as tgf-beta r1 (alk5) inhibitors for the treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023005014A Division JP2023052437A (ja) | 2018-12-27 | 2023-01-17 | がんの処置のためのｔｇｆ－ベータｒ１（ａｌｋ５）阻害剤としての（ピリジン－２－イル）アミン誘導体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022517730A JP2022517730A (ja) | 2022-03-10 |
| JPWO2020139636A5 JPWO2020139636A5 (https=) | 2022-12-16 |
| JP2022517730A5 true JP2022517730A5 (https=) | 2022-12-16 |
| JP7515049B2 JP7515049B2 (ja) | 2024-07-12 |
Family
ID=69185691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536757A Active JP7515049B2 (ja) | 2018-12-27 | 2019-12-17 | がんの処置のためのｔｇｆ－ベータｒ１（ａｌｋ５）阻害剤としての（ピリジン－２－イル）アミン誘導体 |
| JP2023005014A Pending JP2023052437A (ja) | 2018-12-27 | 2023-01-17 | がんの処置のためのｔｇｆ－ベータｒ１（ａｌｋ５）阻害剤としての（ピリジン－２－イル）アミン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023005014A Pending JP2023052437A (ja) | 2018-12-27 | 2023-01-17 | がんの処置のためのｔｇｆ－ベータｒ１（ａｌｋ５）阻害剤としての（ピリジン－２－イル）アミン誘導体 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12102626B2 (https=) |
| EP (1) | EP3902796B1 (https=) |
| JP (2) | JP7515049B2 (https=) |
| KR (1) | KR102832376B1 (https=) |
| CN (1) | CN113348167B (https=) |
| AR (1) | AR117539A1 (https=) |
| AU (1) | AU2019417418B2 (https=) |
| BR (1) | BR112021007006A2 (https=) |
| CA (1) | CA3117838A1 (https=) |
| EA (1) | EA202191619A1 (https=) |
| ES (1) | ES2972516T3 (https=) |
| IL (1) | IL284266B2 (https=) |
| MX (1) | MX2021007738A (https=) |
| SG (1) | SG11202103457PA (https=) |
| TW (1) | TWI884934B (https=) |
| WO (1) | WO2020139636A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021259419A1 (en) | 2020-04-21 | 2022-11-10 | Lexicon Pharmaceuticals, Inc. | AAK1 inhibitors for use in treating viral infections |
| US11666575B2 (en) | 2020-04-21 | 2023-06-06 | Lexicon Pharmaceuticals, Inc. | Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections |
| CN113214111A (zh) * | 2021-04-30 | 2021-08-06 | 上海立科化学科技有限公司 | 3-（2-氰基苯基）丙酸及4-氰基-1-茚满酮的制备方法 |
| US12263576B2 (en) | 2021-08-19 | 2025-04-01 | Hyundai Mobis Co., Ltd. | Robot system for automated assembly of modular component |
| MX2024008704A (es) * | 2022-01-14 | 2024-07-22 | Shanghai Hansoh Biomedical Co Ltd | Derivado policiclico que contiene piridina, y metodo de preparacion de este y uso de este. |
| CN121554469B (zh) * | 2026-01-23 | 2026-04-17 | 四川大学华西医院 | 一种alk5 protac化合物及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1397364B1 (en) | 2001-05-24 | 2007-07-25 | Eli Lilly And Company | Novel pyrrole derivatives as pharmaceutical agents |
| UA80571C2 (en) | 2002-11-22 | 2007-10-10 | Lilly Co Eli | Quinolinyl-pyrrolopyrazoles |
| WO2005080377A1 (ja) | 2004-02-20 | 2005-09-01 | Kirin Beer Kabushiki Kaisha | TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物 |
| WO2009022171A1 (en) * | 2007-08-13 | 2009-02-19 | Astrazeneca Ab | Pyridinyiioxy pyridines as alk5 inhibitors |
| US8080568B1 (en) | 2010-06-29 | 2011-12-20 | Ewha University - Industry Collaboration Foundation | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| BR112013028430A2 (pt) * | 2011-05-04 | 2017-08-01 | Merck Sharp & Dohme | composto, composição farmacêutica, método para tratar uma doença ou condição mediada por tirosina quinase do baço (syk), e, uso de uma quantidade terapeuticamente eficiente do composto |
| EP2900665B1 (en) * | 2012-09-28 | 2018-01-03 | Merck Sharp & Dohme Corp. | Triazolyl derivatives as syk inhibitors |
| EP2934525B1 (en) * | 2012-12-21 | 2019-05-08 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors |
| WO2014155300A2 (en) * | 2013-03-28 | 2014-10-02 | Aurigene Discovery Technologies Limited | Substitued pyrimidine amine derivatives as tak-1 inhibitors |
| HRP20201384T1 (hr) | 2014-01-01 | 2020-11-27 | Medivation Technologies Llc | Spojevi i postupci njihove upotrebe |
| CN106536507B (zh) | 2014-04-08 | 2020-04-07 | 里格尔药品股份有限公司 | 作为TGF-β抑制剂的2,3-二取代的吡啶化合物及其使用方法 |
| JO3336B1 (ar) | 2014-10-07 | 2019-03-13 | Lilly Co Eli | مركبات أمينو بيريديلوكسي بيرازول |
| US10702527B2 (en) * | 2015-06-12 | 2020-07-07 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| KR20180032611A (ko) | 2015-07-23 | 2018-03-30 | 브리스톨-마이어스 스큅 컴퍼니 | Tgf 베타 수용체 길항제 |
| WO2020103817A1 (zh) | 2018-11-20 | 2020-05-28 | 南京圣和药业股份有限公司 | TGF-βR1抑制剂及其应用 |
| EP3990445A4 (en) | 2019-06-25 | 2023-07-05 | InventisBio Co., Ltd. | HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARATION AND THEIR METHODS OF USE |
| CN112707902B (zh) | 2020-03-23 | 2022-04-15 | 杭州阿诺生物医药科技有限公司 | TGF-β受体抑制剂 |
-
2019
- 2019-12-17 CA CA3117838A patent/CA3117838A1/en active Pending
- 2019-12-17 JP JP2021536757A patent/JP7515049B2/ja active Active
- 2019-12-17 KR KR1020217021785A patent/KR102832376B1/ko active Active
- 2019-12-17 EA EA202191619A patent/EA202191619A1/ru unknown
- 2019-12-17 IL IL284266A patent/IL284266B2/en unknown
- 2019-12-17 AU AU2019417418A patent/AU2019417418B2/en active Active
- 2019-12-17 WO PCT/US2019/066993 patent/WO2020139636A1/en not_active Ceased
- 2019-12-17 MX MX2021007738A patent/MX2021007738A/es unknown
- 2019-12-17 BR BR112021007006-0A patent/BR112021007006A2/pt unknown
- 2019-12-17 ES ES19839715T patent/ES2972516T3/es active Active
- 2019-12-17 CN CN201980086920.0A patent/CN113348167B/zh active Active
- 2019-12-17 EP EP19839715.0A patent/EP3902796B1/en active Active
- 2019-12-17 SG SG11202103457PA patent/SG11202103457PA/en unknown
- 2019-12-17 US US17/299,696 patent/US12102626B2/en active Active
- 2019-12-25 TW TW108147526A patent/TWI884934B/zh active
- 2019-12-27 AR ARP190103894A patent/AR117539A1/es unknown
-
2023
- 2023-01-17 JP JP2023005014A patent/JP2023052437A/ja active Pending
-
2024
- 2024-08-05 US US18/795,000 patent/US20240398776A1/en active Pending